PEMBROLIZUMAB

pembrolizumab 100 mg/4 mL injection, 4 mL vial

PEMBROLIZUMAB (10424P)

pembrolizumab 100 mg/4 mL injection, 4 mL vial
10424P
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 10705)

Indication: Unresectable Stage III or Stage IV malignant melanoma
Treatment phase: Continuing treatment - 3 weekly treatment regimen
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 200 mg # of repeats: 7 DPMA: $7,503.74 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Keytruda
(pembrolizumab 100 mg/4 mL injection, 4 mL vial)